Kalytera Therapeutics Inc (OTCMKTS:KALTF) has terminated the previously signed Letter of Intent to take over Stero Biotechs, Ltd. Chief Executive Officer and President of Kalytera said...
Kalytera Therapeutics Inc (OTCMKTS:KALTF) will take over Stero Biotechs, Ltd for $30 million. The company will issue its common shares worth $15 million to the shareholders...
Investor sentiments on Kalytera Therapeutics Inc. (OTCMKTS:KALTF) have edged higher on the confirmation that the company has made significant progress on the development of a new...
Kalytera Therapeutics Inc (OTCMKTS:KALTF) today spoke in relation to its lead product development program. The company seeks to undertake an evaluation on cannabidiol (“CBD”). It hopes...
Kalytera Therapeutics Inc. (OTCMKTS:KALTF) has had to venture into the debt market in a bid to raise much-needed funds to pay off milestone payments owing to...
